AI assistant
Sending…
NANOVIRICIDES, INC. — Director's Dealing 2015
Sep 25, 2015
34915_dirs_2015-09-24_d7268587-d821-463a-836a-74cca51f7b16.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: NANOVIRICIDES, INC. (NNVC)
CIK: 0001379006
Period of Report: 2015-09-22
Reporting Person: Seymour Eugene (Director, Chief Executive Officer)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2015-09-22 | Common Stock, par value $0.001 per share | M | 104384 | $0.35 | Acquired | 1287286 | Direct |
| 2015-09-22 | Common Stock, par value $0.001 per share | F | 38472 | $1.30 | Disposed | 1248814 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2015-09-18 | Common Stock Options | $0.35 | M | 142856 | Disposed | 2015-09-26 | Common Stock (142856) | Direct |
Footnotes
F1: Does not include 425,571 shares of Series A Convertible Preferred Stock (the "Series A") which vote at the rate of nine votes per share of Series A and is convertible into shares of Common Stock upon a change of control of the Company or upon the Common Stock achieving certain trading prices.
F2: Reflects 38,472 shares withheld by the Issuer at the market price of $1.30 per share, less an exercise price of $0.35 per share, to fund the cashless exercise of 142,856 options.
More from NANOVIRICIDES, INC.
Regulatory Filings
2026
May 21
Regulatory Filings
2026
May 20
Regulatory Filings
2026
May 18
Interim / Quarterly Report
2026
May 14
Interim / Quarterly Report
2026
Feb 17
Regulatory Filings
2025
Dec 30
Regulatory Filings
2025
Dec 22
Regulatory Filings
2025
Dec 16
Regulatory Filings
2025
Dec 15
Regulatory Filings
2025
Nov 26